It has been demonstrated that mutated BRAFV600E suppresses the activity of AMPK by promoting inhibitory phosphorylation of its upstream kinase (LKB1) by ERK1/2 and that this AMPK inhibition is critical for melanoma cell proliferation and anchorage-independent growth [52]. Here, STK11 is linked to melanoma.